Cancer is the second leading cause of
mortality in India and the rest of the world.
The prevalence of cancer is established to be over 3 million in India, with more than 550,000 deaths every year.
WE’RE HERE TO HELP CHANGE THIS. WE ARE BCPBF
Founded in 2004 by Dr Sameer Kaul, a renowned cancer specialist, The Breast Cancer Patients Benefit Foundation (BCPBF) has been actively providing help to financially-constrained cancer patients in India and neighbouring countries. In the interim, BCPBF extends support and treatment to poor patients with all forms of cancer.
HOW YOU CAN HELP
HOW YOUR DONATION HELPS
PEOPLE SCREENED AT OUR FREE MEDICAL CAMPS
PATIENTS HAVE BEEN GIVEN FINANCIAL HELP FOR TREATMENT
PATIENTS HAVE BEEN HELPED THROUGH OUR MEDICINE BANK
The Gulmarg Declaration
An intensive workshop on Locally Advanced Breast Cancer, culminating in a consensus document on guidelines for management of Indian patients. Held on Saturday, 10th October 2015 at The Khyber, Gulmarg, Kashmir, the event was well attended by eminent breast cancer experts and managers drawn from the public and private sector from all over India and was supported by the Ministry of Health, Govt. of India.
TWEET TO US
- Twitter said: "Sorry, that page does not exist."
Pills to improve imaging techniques involved in breast cancer
Current diagnostics methods like mammograms — X-rays of breast tissue — often identify a lump’s location and size but cannot distinguish between cancerous and benign growths. “Screening can potentially catch the disease early in some patients but false positives can lead to unnecessary, aggressive treatments in patients who don’t need them. We don’t know how to select the right patients to treat. Our work could help change that,” said Greg Thurber, doctoral researcher from University of Michigan in US. The oral pill is embedded with an imaging agent that selectively binds to cancer cells or blood vessels that are unique to tumours. Once attached to its target, it lights up under the near-infrared light. Although at this wavelength, fluorescent tumours can only be detected one to two cm deep, the researchers indicated that given the elasticity of breast tissue, pairing the technique with ultrasound in the same instrument should be able to detect most cancers.
Breast cancer: Taking hormonal drugs for up to 15 years can reduce risk – BBC News, 5 June 2016
Taking hormonal drugs for up to 15 years reduces the risk of breast cancers coming back, a landmark study suggests. The trial, involving 1,918 patients, which had top billing at the world’s largest cancer conference, showed the risk was cut by a third. Experts described it as a “big deal” that will change treatment for millions of women. But they warned there were risks, including osteoporosis. Globally, 1.7 million women are diagnosed with breast cancer around the world each year. Around 80% of the tumours are fuelled by the female sex hormone, oestrogen. Such cancers have a low but persistent risk of returning that lasts for years. The trial, carried out on post-menopausal women, doubled aromatase inhibitor treatment from five to 10 years. The data, presented to the American Society of Clinical Oncology (ASCO), showed that cancer recurrence was cut by 34%. Experts said it should be a decision between doctor and patient whether to continue.